Association of PD-L1 combined positive score with disease control and response kinetics with first-line pembrolizumab-based therapy in metastatic triple-negative breast cancer: results from routine clinical practice in Poland.
- DOI
- 10.1007/s12094-026-04442-1
- Published
- 2026 Jun 10
- Container
- Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s12094-026-04442-1,
title = {Association of PD-L1 combined positive score with disease control and response kinetics with first-line pembrolizumab-based therapy in metastatic triple-negative breast cancer: results from routine clinical practice in Poland.},
author = {Pieniążek M and Świderska K and Konieczna A and Danielewicz I and Winsko-Szczęsnowicz K and Roman A and Żubrowska J and Meluch M and Wronowicz J and Czartoryska-Arłukowicz B and Jarząb M and Łacko A and Püsküllüoğlu M},
year = {2026},
journal = {Clinical \& translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico},
doi = {10.1007/s12094-026-04442-1},
url = {https://doi.org/10.1007/s12094-026-04442-1}
}RIS
TY - JOUR TI - Association of PD-L1 combined positive score with disease control and response kinetics with first-line pembrolizumab-based therapy in metastatic triple-negative breast cancer: results from routine clinical practice in Poland. AU - Pieniążek M AU - Świderska K AU - Konieczna A AU - Danielewicz I AU - Winsko-Szczęsnowicz K AU - Roman A AU - Żubrowska J AU - Meluch M AU - Wronowicz J AU - Czartoryska-Arłukowicz B AU - Jarząb M AU - Łacko A AU - Püsküllüoğlu M PY - 2026 JO - Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico DO - 10.1007/s12094-026-04442-1 UR - https://doi.org/10.1007/s12094-026-04442-1 ER -
APA
M, P., K, Ś., A, K., I, D., K, W., A, R., J, Ż., M, M., J, W., B, C., M, J., A, Ł., & M, P. (2026). Association of PD-L1 combined positive score with disease control and response kinetics with first-line pembrolizumab-based therapy in metastatic triple-negative breast cancer: results from routine clinical practice in Poland.. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. https://doi.org/10.1007/s12094-026-04442-1
Source records
- pubmed · retrieved 2026-09-26T01:40:54.057Z